Financing ·
Smith+Nephew accepts $250M of its 2.032% Senior Notes due 2030 at a price of U.S.$878.90 per U.S.$1,000 principal amount
SNNSmith & Nephew PLC
Smith+Nephew announced the results of its cash tender offer for up to $250 million of its outstanding 2.032% Senior Notes due 2030. The aggregate principal amount of notes validly tendered and not withdrawn was $431,825,000, exceeding the maximum tender amount and triggering a proration scaling factor of 57.995%. The company accepted $250,000,000 in principal amount at a consideration of U.S.$878.90 per U.S.$1,000 principal amount. Accepted notes will be canceled, and the settlement date is expected to be September 18, 2026. Smith+Nephew operates in the medical technology industry, focusing on the repair, regeneration, and replacement of soft and hard tissue through orthopaedics, sports medicine, and wound management products.